As of 2025-05-17, the EV/EBITDA ratio of HOOKIPA Pharma Inc (HOOK) is 0.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HOOK's latest enterprise value is -20.87 mil USD. HOOK's TTM EBITDA according to its financial statements is -37.89 mil USD. Dividing these 2 quantities gives us the above HOOK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 13.4x | 13.3x |
| Forward P/E multiples | 19.7x - 29.8x | 20.7x |
| Fair Price | (58.54) - (38.87) | (50.12) |
| Upside | -3852.2% - -2591.6% | -3312.5% |
| Date | EV/EBITDA |
| 2025-05-15 | 0.59 |
| 2025-05-14 | 0.60 |
| 2025-05-13 | 0.61 |
| 2025-05-12 | 0.62 |
| 2025-05-09 | 0.63 |
| 2025-05-08 | 0.58 |
| 2025-05-07 | 0.53 |
| 2025-05-06 | 0.58 |
| 2025-05-05 | 0.64 |
| 2025-05-02 | 0.62 |
| 2025-05-01 | 0.63 |
| 2025-04-30 | 0.75 |
| 2025-04-29 | 0.78 |
| 2025-04-28 | 0.79 |
| 2025-04-25 | 0.78 |
| 2025-04-24 | 0.78 |
| 2025-04-23 | 0.80 |
| 2025-04-22 | 0.81 |
| 2025-04-21 | 0.81 |
| 2025-04-17 | 0.80 |
| 2025-04-16 | 0.80 |
| 2025-04-15 | 0.80 |
| 2025-04-14 | 0.81 |
| 2025-04-11 | 0.81 |
| 2025-04-10 | 0.81 |
| 2025-04-09 | 0.80 |
| 2025-04-08 | 0.81 |
| 2025-04-07 | 0.79 |
| 2025-04-04 | 0.78 |
| 2025-04-03 | 0.78 |
| 2025-04-02 | 0.76 |
| 2025-04-01 | 0.72 |
| 2025-03-31 | 0.70 |
| 2025-03-28 | 0.67 |
| 2025-03-27 | 0.67 |
| 2025-03-26 | 0.66 |
| 2025-03-25 | 0.66 |
| 2025-03-24 | 0.66 |
| 2025-03-21 | 0.65 |
| 2025-03-20 | 0.66 |
| 2025-03-19 | 0.66 |
| 2025-03-18 | 0.65 |
| 2025-03-17 | 0.67 |
| 2025-03-14 | 0.68 |
| 2025-03-13 | 0.68 |
| 2025-03-12 | 0.65 |
| 2025-03-11 | 0.69 |
| 2025-03-10 | 0.67 |
| 2025-03-07 | 0.64 |
| 2025-03-06 | 0.63 |